RWReinhard Welp

Reinhard Welp

*This is an algorithmically generated author record based on publicly available information.

Reinhard Welp has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Wagner

    Specialized Diabetes Practice, Saaldorf, Germany

    1 shared publication
  • Dpv Initiative—German Bmbf Competence Network Diabetes Mellitus

    ¶Membership of the DPV consortium is listed in the Acknowledgments

    1 shared publication
  • Erhard Siegel

    Department of Internal Medicine, St. Josefs Hospital, Heidelberg, Germany

    1 shared publication
  • Hans-Peter Hammes

    5th Medical Clinic, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

    1 shared publication
  • Hans-Peter Kempe

    Centre for Diabetes and Nutrition Ludwigshafen, Ludwigshafen, Germany

    1 shared publication
  • Reinhard W. Holl

    Institute of Epidemiology and Medical Biometry, University Medical Centre, Ulm, Germany

    1 shared publication

Latest Publications

  • Open Access

    Risk Factors for Retinopathy and DME in Type 2 Diabetes—Results from the German/Austrian DPV Database

    by Hans-Peter Hammes, Reinhard Welp, Hans-Peter Kempe, Christian Wagner, Erhard Siegel, Reinhard W. Holl, Dpv Initiative—German Bmbf Competence Network Diabetes Mellitus

    To assess the prevalence and risk factors for early and severe diabetic retinopathy and macular edema in a large cohort of patients with type 2 diabetes Retinopathy grading (any retinopathy, severe retinopathy, diabetic macular edema) and risk factors of 64784 were prospectively recorded between January 2000 and March 2013 and analyzed by Kaplan–Meier analysis and logistic regression. Retinopathy was present in 20.12% of subjects, maculopathy was found in 0.77%. HbA1c > 8%, microalbuminuria, hypertension, BMI > 35 kg/m2 and male sex were significantly associated with any retinopathy, while HbA1c and micro- and macroalbuminuria were the strongest risk predictors for severe retinopathy. Presence of macroalbuminuria increased the risk for DME by 177%. Retinopathy remains a significant clinical problem in patients with type 2 diabetes. Metabolic control and blood pressure are relevant factors amenable to treatment. Concomitant kidney disease identifies high risk patients and should be emphasized in interdisciplinary communication.